TaurusAtlas Pro® Balloon Dilatation Catheter approved for market launch. 

 TaurusOne® and TaurusElite® expanded with new AV21 specifications approved. 

 Clinical enrollment completed for TaurusTrio™, TaurusNXT®, and GeminiOne®. Exclusive distribution agreement signed with Nuanyang Medical for mesh stents. 

 Partner JenaValve fully acquired by Edwards Lifesciences. 

 Recognized as a national-level "Specialized and Innovative Little Giant" enterprise. 

 Approved as the Jiangsu Provincial Engineering Research Center for Structural Heart Disease Medical Devices. 

 Zhiweixin Medical opened in Changzhou, Jiangsu. 

 Jialin Biotech commenced operations in Linxia, Gansu.